http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20120572-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34bd4e87ecbca17f16d460ca394e60f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_300f262109a5ded69797a47e6549e6aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ff898c854daa7b1b05e648baf0c716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f1cee1e0f19d67c5fe906c48a866dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d28bb1e51cc76a954614c44263f8737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feee3a3f6b82bd53cfde41806c65e053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a82caf2b08e739e5c971fe7aa2928ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebdeeec39b8ad1e8549760f7927ee774
publicationDate 2012-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20120572-A1
titleOfInvention HANDLING RESISTANT STABILIZED OXIDATION DOSAGE FORM
abstract REFERRED TO A PHARMACEUTICAL DOSAGE FORM IN THE FORM OF A THERMOFORMED TABLET BY HOT MELT EXTRUSION OF A MIXTURE THAT INCLUDES: a) A PHARMACOLOGICALLY ACTIVE INGREDIENT SUCH AS A SELECTED OPIOID OF OXYMORPHONE OXYMORPHONE AND HYDROPHONE HYDROPHONE, HYDROPHONE HYDROPHONE AND HYDROPHONE HYDROPHONE). A MULTICARBOXYLIC ACID SUCH AS MALEIC ACID, FUMARIC ACID, GLUTARIC ACID, MALONIC ACID AND CITRUS ACID, IN AN AMOUNT OF 0.001% TO 5.0% BY WEIGHT BASED ON THE TOTAL WEIGHT OF THE PHARMACEUTICAL FORM AS TALOX, c) ASCORBIC ACID, ALPHA-TOCOPHEROL, VITAMIN E SUCCINATE, BUTYL HYDROXIANISOL, MONOTHIOGLYCERIN, CONIPHERYL BENZOATE, AMONG OTHERS, AND d) A POLYALKYLENE OXIDE. IT IS ALSO REFERRED TO A PREPARATION PROCEDURE. SUCH DOSAGE FORM HAS A STABILIZED OXIDATION AND IS RESISTANT TO HANDLING AND BREAKING
priorityDate 2009-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID242
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409342487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20353
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7291

Total number of triples: 49.